Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.

Trachoma programs have dramatically reduced the prevalence of the ocular chlamydia that cause the disease. Some have hypothesized that immunity to the infection may be reduced because of program success in reducing the incidence of infection, and transmission may then increase. Longitudinal studies...

Full description

Bibliographic Details
Main Authors: Fengchen Liu, Travis C Porco, Kathryn J Ray, Robin L Bailey, Harran Mkocha, Beatriz Muñoz, Thomas C Quinn, Thomas M Lietman, Sheila K West
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC3708821?pdf=render
id doaj-decd3be51a5a4625b05a29ace76bc73d
record_format Article
spelling doaj-decd3be51a5a4625b05a29ace76bc73d2020-11-25T01:46:38ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352013-01-0177e230310.1371/journal.pntd.0002303Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.Fengchen LiuTravis C PorcoKathryn J RayRobin L BaileyHarran MkochaBeatriz MuñozThomas C QuinnThomas M LietmanSheila K WestTrachoma programs have dramatically reduced the prevalence of the ocular chlamydia that cause the disease. Some have hypothesized that immunity to the infection may be reduced because of program success in reducing the incidence of infection, and transmission may then increase. Longitudinal studies of multiple communities would be necessary to test this hypothesis. Here, we quantify transmission using an estimated basic reproduction number based on 32 communities during the first, second, and third years of an antibiotic treatment program. We found that there is little to no increase in the basic reproduction number over time. The estimated linear trend in the basic reproduction number, [Formula: see text], was found to be -0.025 per year, 95% CI -0.167 to 0.117 per year. We are unable to find evidence supporting any loss of immunity over the course of a 3-year program. This is encouraging, as it allows the possibility that repeated mass antibiotic distributions may eliminate infection from even the most severely affected areas.http://europepmc.org/articles/PMC3708821?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Fengchen Liu
Travis C Porco
Kathryn J Ray
Robin L Bailey
Harran Mkocha
Beatriz Muñoz
Thomas C Quinn
Thomas M Lietman
Sheila K West
spellingShingle Fengchen Liu
Travis C Porco
Kathryn J Ray
Robin L Bailey
Harran Mkocha
Beatriz Muñoz
Thomas C Quinn
Thomas M Lietman
Sheila K West
Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.
PLoS Neglected Tropical Diseases
author_facet Fengchen Liu
Travis C Porco
Kathryn J Ray
Robin L Bailey
Harran Mkocha
Beatriz Muñoz
Thomas C Quinn
Thomas M Lietman
Sheila K West
author_sort Fengchen Liu
title Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.
title_short Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.
title_full Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.
title_fullStr Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.
title_full_unstemmed Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.
title_sort assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.
publisher Public Library of Science (PLoS)
series PLoS Neglected Tropical Diseases
issn 1935-2727
1935-2735
publishDate 2013-01-01
description Trachoma programs have dramatically reduced the prevalence of the ocular chlamydia that cause the disease. Some have hypothesized that immunity to the infection may be reduced because of program success in reducing the incidence of infection, and transmission may then increase. Longitudinal studies of multiple communities would be necessary to test this hypothesis. Here, we quantify transmission using an estimated basic reproduction number based on 32 communities during the first, second, and third years of an antibiotic treatment program. We found that there is little to no increase in the basic reproduction number over time. The estimated linear trend in the basic reproduction number, [Formula: see text], was found to be -0.025 per year, 95% CI -0.167 to 0.117 per year. We are unable to find evidence supporting any loss of immunity over the course of a 3-year program. This is encouraging, as it allows the possibility that repeated mass antibiotic distributions may eliminate infection from even the most severely affected areas.
url http://europepmc.org/articles/PMC3708821?pdf=render
work_keys_str_mv AT fengchenliu assessmentoftransmissionintrachomaprogramsovertimesuggestsnoshorttermlossofimmunity
AT traviscporco assessmentoftransmissionintrachomaprogramsovertimesuggestsnoshorttermlossofimmunity
AT kathrynjray assessmentoftransmissionintrachomaprogramsovertimesuggestsnoshorttermlossofimmunity
AT robinlbailey assessmentoftransmissionintrachomaprogramsovertimesuggestsnoshorttermlossofimmunity
AT harranmkocha assessmentoftransmissionintrachomaprogramsovertimesuggestsnoshorttermlossofimmunity
AT beatrizmunoz assessmentoftransmissionintrachomaprogramsovertimesuggestsnoshorttermlossofimmunity
AT thomascquinn assessmentoftransmissionintrachomaprogramsovertimesuggestsnoshorttermlossofimmunity
AT thomasmlietman assessmentoftransmissionintrachomaprogramsovertimesuggestsnoshorttermlossofimmunity
AT sheilakwest assessmentoftransmissionintrachomaprogramsovertimesuggestsnoshorttermlossofimmunity
_version_ 1725018247726628864